The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Abstract Background The effect of additional antimicrobial agents on the clinical outcomes of patients with idiopathic pulmonary fibrosis (IPF) is unclear. Methods We performed comprehensive searches of randomized control trials (RCTs) that compared the clinical efficacy of additional antimicrobial...
Main Authors: | Ching-Yi Chen, Chao-Hsien Chen, Cheng-Yi Wang, Chih-Cheng Lai, Chien-Ming Chao, Yu-Feng Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-021-01839-0 |
Similar Items
-
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy – the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial
by: Kevin J. Anstrom, et al.
Published: (2020-03-01) -
The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial
by: Matthew Hammond, et al.
Published: (2018-02-01) -
Co-trimoxazole to reduce mortality, transplant, or unplanned hospitalisation in people with moderate to very severe idiopathic pulmonary fibrosis: the EME-TIPAC RCT
by: Andrew M Wilson, et al.
Published: (2021-07-01) -
Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
by: Basman M. Fadheel
Published: (2013-04-01) -
The role of long-term doxycycline in patients of idiopathic pulmonaryfibrosis: The results of an open prospective trial
by: Bhattacharyya Parthasarathi, et al.
Published: (2009-01-01)